Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122160) titled 'Effective Dose of Taigilidine Combined with Propofol for Inhibiting Cervical Dilation Response in Patients of Different Ages during Hysteroscopic Surgery' on April 9.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Fudan University Zhongshan Hospital Xiamen Branch
Condition:
Intrauterine space-occupying lesion
Intervention:
Adult group (18-60 years):Different concentrations of Taigilidine injection
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-04-10
Target Sample Size: Adult group (18-60 years):54;Elderly group (>=60 years):54;
Countries of Recr...